Abiopharma

🔍 Tan Irving (Director)

Company: WESTERN DIGITAL CORP (WDC)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 32 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 366,347.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 476 shares of Common Stock at $450.75 per share (Direct)
  Date: 2026-08-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 365,871.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 16,548 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 382,419.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 42 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 382,461.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,314 shares of Common Stock at $468.88 per share (Direct)
  Date: 2026-08-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 379,147.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: by Personal Inv. Co. | shares_owned_after: 209,000.00
• Sold 32 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 816.35 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 42 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 773.94 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The dividend equivalent rights were converted into, and paid in the form of, shares of the Issuer's common stock on a one-for-one basis in connection with the vesting of restricted stock units to which the dividend equivalent rights relate. A cash amount was also paid to the holder to settle a fractional dividend equivalent right.
• F2: Since the date of the Reporting Person's last Form 4, the Reporting Person transferred 209,000 shares of the Issuer's common stock to the Reporting Person's personal investment company, organized under the laws of the Bahamas, of which the Reporting Person is the sole shareholder. The transfer constituted a change in form of beneficial ownership exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
• F3: Payment of tax obligation by withholding securities incident to the vesting of securities in accordance with Rule 16b-3(e).
• F4: Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.